BSE filing, NSE: THEMISMED. Summary written from the filing by ALFA Finder's alert engine.
Themis Medicare Ltd: key numbers
- Share price
- ₹98.44
- Market cap
- ₹906.6 Cr
- Revenue (annual)
- ₹342.2 Cr
- Net profit (annual)
- ₹1.14 Cr
- P/E (TTM)
- 22.7×Sector 46.1×
- Promoter holding
- 67.11%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Themis Medicare Ltd
All →Themis Medicare Share Pledge
Promoter Vividhmargi pledged 15 lakh Themis Medicare shares for a Rs 135 Crore borrowing. Total encumbrance rises to 4.89% of capital.
- Value
- ₹135.0 Cr
Themis Medicare Management Change
Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.
Themis Medicare Annual General Meeting
Themis Medicare seeks shareholder approval via postal ballot for a special resolution re-appointing Mr. Bhaskar Iyer as Independent Director for a second five-year term. Remote e-voting runs 24 October to 22 November 2026.
Themis Medicare Other Announcement
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Themis Medicare Credit Rating
CARE Ratings downgraded Themis Medicare's long-term and short-term bank facility ratings. The downgrade reflects deteriorating profitability, heightened competition, and weak debt coverage indicators.
Themis Medicare Other Announcement
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. This is a routine regulatory disclosure under Regulation 31.
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.